Arcellx Stock Investor Sentiment

ACLX Stock  USD 89.41  1.03  1.14%   
Slightly above 66% of Arcellx's investor base is looking to short. The analysis of the overall investor sentiment regarding Arcellx suggests that many traders are alarmed. Arcellx's investing sentiment can be driven by a variety of factors including economic data, Arcellx's earnings reports, geopolitical events, and overall market trends.
  

Arcellx Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Arcellx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over two weeks ago at zacks.com         
Disposition of 25787 shares by Patel Kavita of Arcellx at 105.4607 subject to Rule 16b-3
zacks News
over two weeks ago at zacks.com         
Moderna Q3 Earnings and Revenues Surpass Estimates
zacks News
over two weeks ago at finance.yahoo.com         
Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
Yahoo News
over two weeks ago at zacks.com         
Disposition of 8478 shares by Patel Kavita of Arcellx at 99.2995 subject to Rule 16b-3
zacks News
over two weeks ago at investing.com         
Arcellx shares target upgraded, maintains buy on positive trial data
Investing News at Macroaxis
over two weeks ago at investing.com         
Arcellx stock target increased, rating held on positive trial data
Investing News at Macroaxis
over two weeks ago at benzinga.com         
Lululemon To Rally Around 19 Here Are 10 Top Analyst Forecasts For Wednesday
benzinga news
over two weeks ago at businesswire.com         
Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or...
businesswire News
over two weeks ago at seekingalpha.com         
Arcellx issues updates on anito-cel clinical trials
seekingalpha News
over two weeks ago at thelincolnianonline.com         
Arcellx Releases Clinical Data from Phase 1 and iMMagine-1 Studies for Multiple Myeloma Patients On ...
news
over three weeks ago at finance.yahoo.com         
Arcellx Surged in Q3. Heres Why
Yahoo News
over three weeks ago at news.google.com         
Arcellx shares target increased, Outperform upheld as ASH data release nears - Investing.com
Google News at Macroaxis
over three weeks ago at simplywall.st         
A Look At The Fair Value Of Arcellx, Inc.
Simply Wall St News at Macroaxis
over a month ago at thelincolnianonline.com         
Moody Aldrich Partners LLC Sells 532 Shares of Arcellx, Inc.
news
over a month ago at gurufocus.com         
Perceptive Advisors LLC Acquires New Stake in Inhibikase Therapeutics Inc
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Arcellx that are available to investors today. That information is available publicly through Arcellx media outlets and privately through word of mouth or via Arcellx internal channels. However, regardless of the origin, that massive amount of Arcellx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arcellx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arcellx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arcellx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arcellx alpha.

Arcellx Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Behbahani Ali of 8011 shares of Arcellx at 51.3 subject to Rule 16b-3
09/06/2024
2
Disposition of 1500 shares by Patel Kavita of Arcellx at 74.41 subject to Rule 16b-3
09/10/2024
3
Disposition of 8726 shares by Michelle Gilson of Arcellx at 77.8809 subject to Rule 16b-3
09/17/2024
4
Arcellx, Inc. Position Lessened by Perceptive Advisors LLC - MarketBeat
09/30/2024
5
Disposition of 1500 shares by Patel Kavita of Arcellx at 82.24 subject to Rule 16b-3
10/01/2024
6
Disposition of 1500 shares by Patel Kavita of Arcellx at 89.69 subject to Rule 16b-3
10/22/2024
7
A Look At The Fair Value Of Arcellx, Inc.
10/28/2024
8
Arcellx Releases Clinical Data from Phase 1 and iMMagine-1 Studies for Multiple Myeloma Patients On November 5, 2024, Arcellx, Inc. made public an abstract cont...
11/05/2024
9
Lululemon To Rally Around 19 Here Are 10 Top Analyst Forecasts For Wednesday
11/06/2024
10
Disposition of 8478 shares by Patel Kavita of Arcellx at 99.2995 subject to Rule 16b-3
11/07/2024
11
Disposition of 25787 shares by Patel Kavita of Arcellx at 105.4607 subject to Rule 16b-3
11/08/2024
12
Disposition of 3005 shares by Patel Kavita of Arcellx at 106.9083 subject to Rule 16b-3
11/11/2024
13
arcellx CFO Michelle Gilson sells 1.24 million in stock
11/13/2024
14
Disposition of 100 shares by Michelle Gilson of Arcellx at 95.0 subject to Rule 16b-3
11/15/2024
15
Acquisition by Michelle Gilson of 3000 shares of Arcellx at 8.66 subject to Rule 16b-3
11/19/2024

Additional Tools for Arcellx Stock Analysis

When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.